Moreover, re-analysis of the database revealed that high YBX1 expression is associated with poor prognosis in human breast and ovarian cancers (Figure 5B), suggesting that YBX1 promotes cancer progression via sEVs containing tumorigenic SATII RNA. Here, YBX1 is linked to ovarian carcinoma.